Publication | Open Access
Phase II Study of Dutasteride for Recurrent Prostate Cancer During Androgen Deprivation Therapy
54
Citations
15
References
2008
Year
Dutasteride rarely produces biochemical responses in men with castration recurrent prostate cancer. However, further study is warranted given its favorable safety profile.
| Year | Citations | |
|---|---|---|
Page 1
Page 1